HSA — authorised 17 April 1980
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
HSA authorised Oxytocin 5 Usp Units In Dextrose 5% on 17 April 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 17 April 1980.
NOVARTIS holds the Singaporean marketing authorisation.